Jyothy Labs
FMCG · NSE
↓ 53.9% vs fair value
52W Low
₹196
+4.5% from low
52W High
₹365
-43.8% from high
Valuation Gauge
Current Price
₹205
Fair Value
₹133
Fair Value Analysis
₹133
Based on free cash flow projections and balance sheet strength analysis and earnings growth potential for FMCG sector companies | ROCE improving (latest 23.7%) — capital allocation becoming more efficient.
Cash Flow Analysis
50% weight
Balance Sheet Value
30% weight
Growth Valuation
20% weight
Price vs Market
Shareholding Pattern
Stock Health Score
Financially Healthy
Profitability
ROE of 17.6% is acceptable for FMCG sector (benchmark: 25%)
Debt & Leverage
D/E ratio of 0.0x is well within the FMCG sector norm of 0.8x — strong balance sheet
Valuation vs Peers
P/E of 22.3x trades at a 37% discount to FMCG sector median (35x) — attractively valued
Cash Flow
FCF margin of 8.9% — healthy cash generation (₹253 Cr)
Earnings Growth
5yr EPS CAGR of 31.8% is well above the FMCG sector average of 6.9% — strong growth
Dividend
Dividend yield of 1.6% provides moderate shareholder returns
Company Health Timeline
10-year financial health at a glance
Sentiment Trend — Last 30 Days
Historical Returns
Key Ratios & Growth
FCF Yield
1.9%
Free cash flow / market cap
Revenue Growth (YoY)
-11.1%
Year-on-year revenue change
Profit Growth (YoY)
-23.2%
Year-on-year PAT change
Operating Cash Flow
₹311 Cr
TTM cash from operations
Key Financials
EPS (TTM)
₹9.9
P/E Ratio
22.3x
P/B Ratio
3.9x
ROE
17.6%
ROCE
22.7%
Debt / Equity
0.04x
Beta
0.56
Div Yield
1.7%
FCF (Cr)
₹253 Cr
Revenue (Cr)
₹2,845 Cr
EPS Growth 5Y
31.8%
Mkt Cap (Cr)
₹8,053 Cr
52W High
₹364.8
52W Low
₹196.2
Book Value/Share
₹56.1
Financial History
| Period | Revenue | Op Profit | OPM% | PAT | EPS |
|---|---|---|---|---|---|
| 2025-03-31 | ₹2.8K Cr | ₹500 Cr | 18.0% | ₹370 Cr | ₹10.09 |
| 2024-03-31 | ₹2.8K Cr | ₹480 Cr | 17.0% | ₹369 Cr | ₹10.06 |
| 2023-03-31 | ₹2.5K Cr | ₹316 Cr | 13.0% | ₹240 Cr | ₹6.53 |
| 2022-03-31 | ₹2.2K Cr | ₹248 Cr | 11.0% | ₹159 Cr | ₹4.41 |
| 2021-03-31 | ₹1.9K Cr | ₹315 Cr | 16.0% | ₹191 Cr | ₹5.43 |
| 2020-03-31 | ₹1.7K Cr | ₹251 Cr | 15.0% | ₹163 Cr | ₹4.64 |
| 2019-03-31 | ₹1.8K Cr | ₹282 Cr | 16.0% | ₹198 Cr | ₹5.59 |
| 2018-03-31 | ₹1.7K Cr | ₹257 Cr | 15.0% | ₹179 Cr | ₹5.12 |
| 2017-03-31 | ₹1.7K Cr | ₹255 Cr | 15.0% | ₹204 Cr | ₹5.73 |
| 2016-03-31 | ₹1.6K Cr | ₹223 Cr | 14.0% | ₹74 Cr | ₹2.16 |
| 2015-03-31 | ₹1.5K Cr | ₹164 Cr | 11.0% | ₹121 Cr | ₹3.35 |
| 2014-03-31 | ₹1.3K Cr | ₹154 Cr | 12.0% | ₹81 Cr | ₹2.25 |
Compounded Growth Rates
Sales Growth
Profit Growth
EPS Growth
Peer Comparison
FMCG| Stock | Price | Fair Value | MoS% | P/E | ROE | Signal |
|---|---|---|---|---|---|---|
Mawana Sugars Limited | ₹102.1 | ₹670.1 | +84.8% | 11.7 | 17.6% | FAIRLY_VALUED |
The Ugar Sugar Works Limited | ₹42.2 | ₹172.9 | +75.6% | 24.7 | 6.0% | UNDERVALUED |
K.M.Sugar Mills Limited | ₹27.7 | ₹97 | +71.4% | 4.7 | 15.2% | UNDERVALUED |
Rana Sugars Limited | ₹12.8 | ₹42.9 | +70.2% | 7.1 | 4.8% | FAIRLY_VALUED |
Dhampur Sugar Mills Limited | ₹145 | ₹411.8 | +64.8% | 13.5 | 7.5% | FAIRLY_VALUED |
Mrs. Bectors Food Specialities Limited | ₹177.7 | ₹270.6 | +34.3% | 39.9 | 10.0% | UNDERVALUED |
Uttam Sugar Mills Limited | ₹246.5 | ₹330.8 | +25.5% | 8.3 | 13.9% | UNDERVALUED |
Prudential Sugar Corporation Limited | ₹15.3 | ₹19 | +19.5% | 8.5 | 2.4% | FAIRLY_VALUED |
Institutional Activity
Bulk deals, block deals, short selling & delivery volume — NSE data
Insider Trading
Share this Stock
Download card · Share on WhatsApp
Share on WhatsApp, Twitter, or any group — each share brings new users to Veritas Quant
Search Interest
Google Trends · India · Last 90 days
Trend data not yet available — check back soon.
Telegram Channels
ET Markets · CNBC TV18 · Moneycontrol · Zee Business · NDTV Profit
No Telegram mentions found yet for JYOTHYLAB.
Analyst Note
4d ago
Jyothy Labs is overvalued by 64.8% with a fair value of ₹133.23, significantly lower than its current trading price of ₹₹205. The company's improving ROCE and strong free cash flow conversion of 253% are notable strengths. However, the stock's sentiment has turned bearish over the last week despite a bullish 30-day trend. This stock may suit value investors looking for a turnaround opportunity.
StockTwits
What traders are saying right now
No StockTwits activity found for JYOTHYLAB.
Jyothy Labs Confirms End of Pril and Fa Licences, Outlines Next Phase of Growth - scanx.trade
Jyothy Labs Ltd. is Rated Hold by MarketsMOJO - Markets Mojo
Jyothy Labs Schedules One-on-One Investor Meeting with Nalanda Capital on May 11, 2026 - scanx.trade
Jyothy Labs Assigned ESG Rating of 64 by NSE for FY 2024-25 - scanx.trade
Stocks to buy in 2026 for long term: HEG, ACC among 5 stocks that could give 20-30% return - The Economic Times
Jyothy Labs FY26: Revenue ₹2,944 Cr; Results Published Under Regulation 33 - scanx.trade
Jyothy Labs Ltd: Valuation Shifts Signal Renewed Price Attractiveness Amid FMCG Sector Dynamics - Markets Mojo
Jyothy Labs Share: Revenue Badhi Par Profit Margin Ki Band Baja Di! - Whalesbook
Buy Jyothy Labs; target of Rs 310: ICICI Securities - Moneycontrol.com
Jyothy Labs Standalone March 2026 Net Sales at Rs 717.41 crore, up 7.73% Y-o-Y - Moneycontrol.com
Jyothy Labs Q4 profit down 12.3% to ₹67.5 cr, FY26 revenue up 3.9% to ₹3,011.85 cr
Jyothy Labs shares fall 2% as Q4 profit drops 12%, operating margin shrinks - CNBC TV18
Jyothy Labs Ltd. is Rated Hold by MarketsMOJO - Markets Mojo
Jyothy Labs Limited board meeting intimation for Q4FY26 under Regulation 29 scheduled on May 4, 2026 - scanx.trade
Jyothy Labs: Why the stock is a buy after 30 pc drop in last 1 year - BusinessLine
What is Dalal Street saying?
r/IndiaInvestments · r/Dalal_Street_Investments · r/IndianStockMarket
No Reddit mentions found yet for JYOTHYLAB.